Document is current
Any future updates will be listed below
-
Authors
Andreazza, Ana C.
Barros, L. Felipe https://orcid.org/0000-0002-6623-4833
Behnke, Alexander https://orcid.org/0000-0002-4128-9627
Ben-Shachar, Dorit
Berretta, Sabina
Chouinard, Virginie-Anne
Do, Kim https://orcid.org/0000-0003-1968-1646
Edwin Thanarajah, Sharmili
Ehrenreich, Hannelore
Falkai, Peter
Ford, Judith
Freyberg, Zachary
Gilbert-Jaramillo, Javier https://orcid.org/0000-0003-1268-2304
Glausier, Jill R. https://orcid.org/0000-0001-9838-3414
Goyal, Manu S.
Hahn, Margaret https://orcid.org/0000-0001-8884-9946
Herculano-Houzel, Suzana
Hofmann, David https://orcid.org/0000-0001-8851-2462
Kolassa, Iris-Tatjana https://orcid.org/0000-0001-7847-1847
Mack, Matthias https://orcid.org/0000-0001-7937-079X
Mavioglu, R. Nehir https://orcid.org/0000-0003-4154-6475
McCullumsmith, Robert
Milaneschi, Yuri https://orcid.org/0000-0002-3697-6617
Molina, Anthony J. A.
Mujica-Parodi, Lilianne
Öngür, Dost https://orcid.org/0000-0001-8151-5759
Paulus, Martin https://orcid.org/0000-0002-0825-3606
Peleg-Raibstein, Daria
Perry, Ben
Picard, Martin https://orcid.org/0000-0003-2835-0478
Pillinger, Toby
Rae, Caroline
Rothman, Douglas
Sarnyai, Zoltan https://orcid.org/0000-0002-2380-7902
Steiner, Johann
Upthegrove, Rachel https://orcid.org/0000-0001-8204-5103
Vernon, Anthony C.
Wall, Melanie
Weistuch, Corey https://orcid.org/0000-0001-6044-2511
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 4 April 2025
First Online: 25 June 2025
Competing interests
: M.H. has received consultation fees from Merck and Alkermes. Y.M. has received consulting fees from Noema Pharma AG. D.Ö. has received honoraria from Rapport Therapeutics. M.P. is receiving support from KetoSwiss for a project. R.M. conducts reviews for the schizophrenia grant program at Alkermes. Z.S. is the chief scientist at Ally Bio, a brain health supplement start-up. The other authors declare no competing interests.
